Stay updated on Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the remdesivir trial in adults with severe COVID-19, including its terminated status, eligibility criteria, study design, outcomes, and publications.SummaryDifference46%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedA notice appears at the top of the page announcing NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error; its footer shows an updated site revision number.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site’s footer revision indicator changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now presents a 403 Forbidden error instead of the study record content. This indicates the record is currently inaccessible to users.SummaryDifference18%

Stay in the know with updates to Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.